List of life saving transplantations

FamiCord Group is the most experienced bank in Europe in preparing and releasing stem cells for transplantations. We are advancing potential stem cell uses by partnering with leading medical institutions.

Filter by:

No. Cell source Indication Area of medicine Year Type of therapy Country Age
1 cord blood neuroblastoma hematology 2007 standard therapy Poland 8
2 cord blood acute lymphoblastic leukemia hematology 2008 standard therapy Poland 5
3 cord blood cerebral ischemia neurology 2008 experimental therapy Poland 1.5
4 cord blood myelodysplastic syndrome hematology 2009 standard therapy Poland 5
5 cord blood pre -B acute lymphoblastic leukemia hematology 2010 standard therapy Hungary 1.5
6 cord blood Fanconi anemia hematology 2011 standard therapy Poland 12
7 cord blood acute myeloid leukemia hematology 2011 standard therapy Hungary 2
8 cord blood acute lymphoblastic leukemia hematology 2011 standard therapy Poland 5
9 cord blood histiocytosis hematology 2011 standard therapy Poland 2.5
10 cord blood chronic granulomatous disease hematology 2011 standard therapy Poland 7.5
11 cord tissue (Wharton's jelly) acute graft versus host disease hematology 2011 experimental therapy Poland 17.2
12 cord tissue (Wharton's jelly) acute graft versus host disease hematology 2012 experimental therapy Poland 19.7
13 cord tissue (Wharton's jelly) acute graft versus host disease hematology 2012 experimental therapy Poland 7.1
14 cord tissue (Wharton's jelly) acute graft versus host disease hematology 2012 experimental therapy Poland 4.3
15 cord blood severe aplastic anaemia hematology 2012 standard therapy Hungary 3
16 cord blood anaemia, talassemia major hematology 2012 standard therapy Turkey 6
17 cord blood talassemia major, acute lymphoblastic leukemia hematology 2012 standard therapy Turkey 3.5
18 cord blood T-acute lymphoblastic leukemia hematology 2012 standard therapy Turkey 5
19 cord tissue (Wharton's jelly) acute graft versus host disease hematology 2013 experimental therapy Poland 18.9
20 cord blood aplastic anaemia hematology 2013 standard therapy Poland 3
21 cord blood acute myeloid leukemia hematology 2013 standard therapy Poland 3
22 cord tissue (Wharton's jelly) acute graft versus host disease hematology 2013 experimental therapy Poland 2.11
23 cord tissue (Wharton's jelly) acute graft versus host disease hematology 2013 experimental therapy Poland 3.5
24 cord tissue (Wharton's jelly) acute myeloid leukemia hematology 2013 experimental therapy Poland 3.5
25 cord tissue (Wharton's jelly) chronic graft versus host disease hematology 2013 experimental therapy Poland 18.8
26 cord tissue (Wharton's jelly) chronic graft versus host disease hematology 2013 experimental therapy Poland 17.5
27 cord blood beta-talassemia; agranulocytosis hematology 2013 standard therapy Turkey 8
28 cord blood X - linked lymphoproliferative syndrome hematology 2013 standard therapy Poland 10/12
29 cord tissue (Wharton's jelly) neuropathy neurology 2014 experimental therapy Poland 23.6
30 cord tissue (Wharton's jelly) autism neurology 2014 experimental therapy Poland 12,6
31 cord tissue (Wharton's jelly) acute graft versus host disease hematology 2014 experimental therapy Poland 6
32 cord tissue (Wharton's jelly) central motor coordination impairment after hypoxic ischaemia lesion at birth neurology 2014 experimental therapy Poland 2,1
33 cord tissue (Wharton's jelly) amyotrophic lateral sclerosis neurology 2014 experimental therapy Poland 60,10
34 cord tissue (Wharton's jelly) amyotrophic lateral sclerosis neurology 2014 experimental therapy Poland 24,1
35 cord tissue (Wharton's jelly) autism neurology 2014 experimental therapy Poland 8,3
36 cord tissue (Wharton's jelly) muscular dystrophy neurology 2014 experimental therapy Poland 6
37 cord tissue (Wharton's jelly) birth asphyxia; retinopathy neurology 2014 experimental therapy Poland 11/12
38 cord tissue (Wharton's jelly) cerebral palsy neurology 2014 experimental therapy Poland 4,10
39 cord tissue (Wharton's jelly) cerebral palsy neurology 2014 experimental therapy Poland 15,10
40 cord blood acute lymphoblastic leukemia hematology 2014 standard therapy Turkey 7
41 cord tissue (Wharton's jelly) acute graft versus host disease hematology 2015 experimental therapy Poland 1,4
42 cord tissue (Wharton's jelly) autism neurology 2015 experimental therapy Poland 5,4
43 cord tissue (Wharton's jelly) sclerosis multiplex neurology 2015 experimental therapy Poland 23,2
44 cord tissue (Wharton's jelly) amyotrophic lateral sclerosis neurology 2015 experimental therapy Poland 61,6
45 cord tissue (Wharton's jelly) amyotrophic lateral sclerosis neurology 2015 experimental therapy Poland 61
46 cord tissue (Wharton's jelly) amyotrophic lateral sclerosis neurology 2015 experimental therapy Poland 56
47 cord tissue (Wharton's jelly) amyotrophic lateral sclerosis neurology 2015 experimental therapy Poland 51
48 cord tissue (Wharton's jelly) amyotrophic lateral sclerosis neurology 2015 experimental therapy Poland 65
49 cord tissue (Wharton's jelly) amyotrophic lateral sclerosis neurology 2015 experimental therapy Poland 60
50 cord tissue (Wharton's jelly) amyotrophic lateral sclerosis neurology 2015 experimental therapy Poland 52
51 cord tissue (Wharton's jelly) cerebral palsy neurology 2015 experimental therapy Poland 3,8
52 cord tissue (Wharton's jelly) decerebration rigidity neurology 2015 experimental therapy Poland 9,6
53 cord tissue (Wharton's jelly) bilateral blindness ophthalmology 2015 experimental therapy Poland 36,10
54 cord tissue (Wharton's jelly) acute graft versus host disease hematology 2015 experimental therapy Poland 11/12
55 cord tissue (Wharton's jelly) cerebral palsy neurology 2015 experimental therapy Poland 7,1
56 cord blood acute lymphoblastic leukemia hematology 2015 standard therapy Poland 4
57 cord tissue (Wharton's jelly) cerebral palsy neurology 2015 experimental therapy Poland 15,8
58 cord tissue (Wharton's jelly) ceroid lipofuscinosis neurology 2015 experimental therapy Poland 5,1
59 cord tissue (Wharton's jelly) encephalopathy neurology 2015 experimental therapy Poland 14,5
60 cord tissue (Wharton's jelly) ceroid lipofuscinosis neurology 2015 experimental therapy Poland 7,10
61 cord tissue (Wharton's jelly) autism neurology 2015 experimental therapy Poland 3
62 cord tissue (Wharton's jelly) cerebral palsy neurology 2015 experimental therapy Poland 7,1
63 cord tissue (Wharton's jelly) cerebral palsy neurology 2015 experimental therapy Poland 13,1
64 cord tissue (Wharton's jelly) spina bifida neurology 2015 experimental therapy Poland 2,4
65 cord tissue (Wharton's jelly) amyotrophic lateral sclerosis neurology 2015 experimental therapy Poland 59,4
66 cord tissue (Wharton's jelly) spinal cord injury orthopedics 2015 experimental therapy Poland 31,2
67 cord tissue (Wharton's jelly) cerebral palsy neurology 2015 experimental therapy Poland 5,1
68 cord tissue (Wharton's jelly) autism neurology 2015 experimental therapy Poland 12,5
69 cord tissue (Wharton's jelly) cerebral palsy neurology 2015 experimental therapy Poland 8,11
70 cord tissue (Wharton's jelly) delayed psychomotor development, deafness neurology 2015 experimental therapy Poland 3,3
71 cord tissue (Wharton's jelly) amyotrophic lateral sclerosis neurology 2015 experimental therapy Poland 61,5
72 cord tissue (Wharton's jelly) traumatic encephalopathy neurology 2015 experimental therapy Poland 20,11
73 cord tissue (Wharton's jelly) spinal cord injury orthopedics 2015 experimental therapy Poland 18,8
74 cord tissue (Wharton's jelly) cerebral palsy neurology 2015 experimental therapy Poland 2,7
75 cord tissue (Wharton's jelly) adrenoleukodystrophy; encephalopathy neurology 2015 experimental therapy Poland 23
76 cord tissue (Wharton's jelly) adrenoleukodystrophy neurology 2015 experimental therapy Poland 11,11
77 cord tissue (Wharton's jelly) spinal cord injury orthopedics 2015 experimental therapy Poland 40
78 cord tissue (Wharton's jelly) spinal cord injury orthopedics 2015 experimental therapy Poland 26,1
79 cord tissue (Wharton's jelly) spinal cord injury orthopedics 2015 experimental therapy Poland 37,1
80 cord tissue (Wharton's jelly) amyotrophic lateral sclerosis neurology 2015 experimental therapy Poland 58
81 cord tissue (Wharton's jelly) spinocerebellar ataxia neurology 2015 experimental therapy Poland 35,6
82 cord tissue (Wharton's jelly) spinal muscular atrophy neurology 2015 experimental therapy Poland 11/12
83 cord tissue (Wharton's jelly) spinocerebellar ataxia neurology 2015 experimental therapy Poland 44,6
84 cord tissue (Wharton's jelly) optic neuropathy ophthalmology 2015 experimental therapy Poland 15,8
85 cord tissue (Wharton's jelly) amyotrophic lateral sclerosis neurology 2015 experimental therapy Poland 61,6
86 cord tissue (Wharton's jelly) gonarthrosis orthopedics 2015 experimental therapy Poland 66,2
87 cord tissue (Wharton's jelly) iatrogenic spinal cord injury neurology 2015 experimental therapy Poland 17,2
88 cord tissue (Wharton's jelly) optic neuropathy ophthalmology 2015 experimental therapy Poland 45,10
89 cord tissue (Wharton's jelly) amyotrophic lateral sclerosis neurology 2015 experimental therapy Poland 62
90 cord tissue (Wharton's jelly) acute graft versus host disease hematology 2015 experimental therapy Poland 51,5
91 cord tissue (Wharton's jelly) cerebral palsy neurology 2015 experimental therapy Poland 12,10
92 cord tissue (Wharton's jelly) amyotrophic lateral sclerosis neurology 2015 experimental therapy Poland 26,5
93 cord tissue (Wharton's jelly) amyotrophic lateral sclerosis neurology 2015 experimental therapy Poland 27
94 cord tissue (Wharton's jelly) cerebral palsy neurology 2015 experimental therapy Poland 4,10
95 cord tissue (Wharton's jelly) autism neurology 2015 experimental therapy Poland 6,1
96 cord tissue (Wharton's jelly) autism neurology 2015 experimental therapy Poland 4,6
97 cord tissue (Wharton's jelly) amyotrophic lateral sclerosis neurology 2015 experimental therapy Poland 63,11
98 cord tissue (Wharton's jelly) spinal cord injury orthopedics 2015 experimental therapy Poland 32,10
99 cord tissue (Wharton's jelly) cerebral palsy neurology 2015 experimental therapy Poland 22
100 cord tissue (Wharton's jelly) sclerosis multiplex neurology 2015 experimental therapy Poland 33,3
101 cord tissue (Wharton's jelly) delayed psychomotor development neurology 2015 experimental therapy Poland 3,6
102 cord tissue (Wharton's jelly) spina bifida neurology 2015 experimental therapy Poland 2
103 cord tissue (Wharton's jelly) cerebellar ataxia neurology 2015 experimental therapy Poland 18,7
104 cord tissue (Wharton's jelly) spinocerebellar ataxia neurology 2015 experimental therapy Poland 24,3
105 cord tissue (Wharton's jelly) amyotrophic lateral sclerosis neurology 2015 experimental therapy Poland 67,6
106 cord tissue (Wharton's jelly) autism neurology 2015 experimental therapy Poland 5,6
107 cord tissue (Wharton's jelly) polineuropathy neurology 2015 experimental therapy Poland 74,2
108 cord tissue (Wharton's jelly) amyotrophic lateral sclerosis neurology 2015 experimental therapy Poland 37,6
109 cord tissue (Wharton's jelly) stroke neurology 2015 experimental therapy Poland 62,8
110 cord tissue (Wharton's jelly) amyotrophic lateral sclerosis neurology 2015 experimental therapy Poland 58,10
111 cord tissue (Wharton's jelly) facio-scapulo-humeral muscular dystrophy neurology 2015 experimental therapy Poland 30,1
112 cord tissue (Wharton's jelly) chronic graft versus host disease hematology 2015 experimental therapy Poland 10
113 cord tissue (Wharton's jelly) severe developmental delay neurology 2015 experimental therapy Poland 1,1
114 cord tissue (Wharton's jelly) spinal muscular atrophy neurology 2015 experimental therapy Poland 26,2
115 cord tissue (Wharton's jelly) amyotrophic lateral sclerosis neurology 2015 experimental therapy Poland 46,2
116 cord tissue (Wharton's jelly) autism neurology 2015 experimental therapy Poland 8,7
117 cord tissue (Wharton's jelly) encephalopathy neurology 2015 experimental therapy Poland 8/12
118 cord tissue (Wharton's jelly) acute graft versus host disease hematology 2015 experimental therapy Poland 6,6
119 cord tissue (Wharton's jelly) amyotrophic lateral sclerosis neurology 2015 experimental therapy Poland 48,7
120 cord tissue (Wharton's jelly) spinal cord injury orthopedics 2015 experimental therapy Poland 21,4
121 cord tissue (Wharton's jelly) cerebral palsy neurology 2015 experimental therapy Poland 9,9
122 cord tissue (Wharton's jelly) acute graft versus host disease hematology 2015 experimental therapy Poland 13,4
123 cord tissue (Wharton's jelly) amyotrophic lateral sclerosis neurology 2015 experimental therapy Poland 61,3
124 cord tissue (Wharton's jelly) amyotrophic lateral sclerosis neurology 2015 experimental therapy Poland 54
125 cord tissue (Wharton's jelly) intracranial injury neurology 2015 experimental therapy Poland 24,3
126 cord tissue (Wharton's jelly) stroke neurology 2015 experimental therapy Poland 54,9
127 cord tissue (Wharton's jelly) spinal cord injury orthopedics 2015 experimental therapy Poland 24,7
128 cord tissue (Wharton's jelly) gonarthrosis orthopedics 2015 experimental therapy Poland 65,9
129 cord tissue (Wharton's jelly) leukodystrophy neurology 2015 experimental therapy Poland 18,8
130 cord tissue (Wharton's jelly) spinal cord injury orthopedics 2015 experimental therapy Poland 34,4
131 cord tissue (Wharton's jelly) cerebral palsy neurology 2015 experimental therapy Poland 1,6
132 cord tissue (Wharton's jelly) cerebral palsy neurology 2015 experimental therapy Poland 14,10
133 cord tissue (Wharton's jelly) anterior ischemic optic neuropathy ophthalmology 2015 experimental therapy Poland 54,10
134 cord tissue (Wharton's jelly) cerebral palsy neurology 2015 experimental therapy Poland 16,9
135 cord tissue (Wharton's jelly) retinitis pigmentosa ophthalmology 2015 experimental therapy Poland 34,5
136 cord tissue (Wharton's jelly) cerebellar ataxia neurology 2015 experimental therapy Poland 26,1
137 cord tissue (Wharton's jelly) encephalopathy neurology 2015 experimental therapy Poland 11,2
138 cord tissue (Wharton's jelly) adrenoleukodystrophy; encephalopathy neurology 2015 experimental therapy Poland 8,4
139 cord tissue (Wharton's jelly) cerebral palsy neurology 2016 experimental therapy Poland 10,11
140 cord tissue (Wharton's jelly) amyotrophic lateral sclerosis neurology 2016 experimental therapy Poland 44,5
141 cord tissue (Wharton's jelly) amyotrophic lateral sclerosis neurology 2016 experimental therapy Poland 60,8
142 cord tissue (Wharton's jelly) amyotrophic lateral sclerosis neurology 2016 experimental therapy Poland 32,2
143 cord tissue (Wharton's jelly) spinocerebellar ataxia neurology 2016 experimental therapy Poland 64
144 cord tissue (Wharton's jelly) spinocerebellar ataxia neurology 2016 experimental therapy Poland 62,5
145 cord tissue (Wharton's jelly) autism neurology 2016 experimental therapy Poland 18,4
146 cord tissue (Wharton's jelly) dystrophia progressiva pseudohypertrophica /DMD neurology 2016 experimental therapy Poland 48,8
147 cord tissue (Wharton's jelly) cerebral palsy neurology 2016 experimental therapy Poland 10,3
148 cord tissue (Wharton's jelly) facio-scapulo-humeral muscular dystrophy neurology 2016 experimental therapy Poland 35,3
149 cord tissue (Wharton's jelly) amyotrophic lateral sclerosis neurology 2016 experimental therapy Poland 53,7
150 cord tissue (Wharton's jelly) cerebral palsy neurology 2016 experimental therapy Poland 12,2
151 cord tissue (Wharton's jelly) delayed psychomotor development neurology 2016 experimental therapy Poland 3,10
152 cord tissue (Wharton's jelly) acute graft versus host disease hematology 2016 experimental therapy Poland 14
153 cord tissue (Wharton's jelly) acute graft versus host disease hematology 2016 experimental therapy Poland 6
154 cord tissue (Wharton's jelly) gonarthrosis orthopedics 2016 experimental therapy Poland 65,8
155 cord tissue (Wharton's jelly) leukodystrophy neurology 2016 experimental therapy Poland 2,9
156 cord tissue (Wharton's jelly) amyotrophic lateral sclerosis neurology 2016 experimental therapy Poland 59,4
157 cord blood acute myeloid leukemia hematology 2016 standard therapy Jordan 6
158 cord tissue (Wharton's jelly) autism neurology 2016 experimental therapy Poland 6
159 cord tissue (Wharton's jelly) cerebral palsy neurology 2016 experimental therapy Poland 2,11
160 cord tissue (Wharton's jelly) autism neurology 2016 experimental therapy Poland 12,11
161 cord tissue (Wharton's jelly) cerebral palsy neurology 2016 experimental therapy Poland 9,7
162 cord tissue (Wharton's jelly) atrophy of the optic nerves ophthalmology 2016 experimental therapy Poland 20,3
163 cord tissue (Wharton's jelly) Stargardt's disease ophthalmology 2016 experimental therapy Poland 53
164 cord tissue (Wharton's jelly) spinal cord injury orthopedics 2016 experimental therapy Poland 33,5
165 cord tissue (Wharton's jelly) spinal cord injury orthopedics 2016 experimental therapy Poland 22,2
166 cord tissue (Wharton's jelly) cerebral palsy neurology 2016 experimental therapy Poland 10,3
167 cord tissue (Wharton's jelly) autism neurology 2016 experimental therapy Poland 8,5
168 cord tissue (Wharton's jelly) sclerosis multiplex neurology 2016 experimental therapy Poland 29,11
169 cord tissue (Wharton's jelly) amyotrophic lateral sclerosis neurology 2016 experimental therapy Poland 33,4
170 cord tissue (Wharton's jelly) amyotrophic lateral sclerosis neurology 2016 experimental therapy Poland 37,4
171 cord tissue (Wharton's jelly) amyotrophic lateral sclerosis neurology 2016 experimental therapy Poland 39,3
172 cord tissue (Wharton's jelly) autism neurology 2016 experimental therapy Poland 7,11
173 cord tissue (Wharton's jelly) spinal cord injury orthopedics 2016 experimental therapy Poland 28
174 cord tissue (Wharton's jelly) gonarthrosis orthopedics 2016 experimental therapy Poland 69,6
175 cord tissue (Wharton's jelly) spinal cord injury orthopedics 2016 experimental therapy Poland 33,11
176 cord tissue (Wharton's jelly) spinal cord injury orthopedics 2016 experimental therapy Poland 20,7
177 cord tissue (Wharton's jelly) spinal cord injury orthopedics 2016 experimental therapy Poland 24,5
178 cord tissue (Wharton's jelly) spinal cord injury orthopedics 2016 experimental therapy Poland 25,6
179 cord tissue (Wharton's jelly) autism neurology 2016 experimental therapy Poland 8,5
180 cord tissue (Wharton's jelly) facio-scapulo-humeral muscular dystrophy neurology 2016 experimental therapy Poland 39,10
181 cord tissue (Wharton's jelly) patella cartilage damage orthopedics 2016 experimental therapy Poland 60,10
182 cord tissue (Wharton's jelly) autism neurology 2016 experimental therapy Poland 6,9
183 cord tissue (Wharton's jelly) sclerosis multiplex neurology 2016 experimental therapy Poland 44,8
184 cord tissue (Wharton's jelly) facio-scapulo-humeral muscular dystrophy neurology 2016 experimental therapy Poland 25,4
185 cord tissue (Wharton's jelly) autism neurology 2016 experimental therapy Poland 10,10
186 cord tissue (Wharton's jelly) amyotrophic lateral sclerosis neurology 2016 experimental therapy Poland 63,2
187 cord tissue (Wharton's jelly) amyotrophic lateral sclerosis neurology 2016 experimental therapy Poland 54,11
188 cord tissue (Wharton's jelly) amyotrophic lateral sclerosis neurology 2016 experimental therapy Poland 53,9
189 cord tissue (Wharton's jelly) amyotrophic lateral sclerosis neurology 2016 experimental therapy Poland 46,9
190 cord tissue (Wharton's jelly) amyotrophic lateral sclerosis neurology 2016 experimental therapy Poland 58
191 cord tissue (Wharton's jelly) chronic graft versus host disease hematology 2016 experimental therapy Poland 19,2
192 cord tissue (Wharton's jelly) amyotrophic lateral sclerosis neurology 2016 experimental therapy Poland 55
193 cord tissue (Wharton's jelly) amyotrophic lateral sclerosis neurology 2016 experimental therapy Poland 58,1
194 cord tissue (Wharton's jelly) amyotrophic lateral sclerosis neurology 2016 experimental therapy Poland 61,7
195 cord tissue (Wharton's jelly) amyotrophic lateral sclerosis neurology 2016 experimental therapy Poland 52,6
196 cord tissue (Wharton's jelly) amyotrophic lateral sclerosis neurology 2016 experimental therapy Poland 59,11
197 cord tissue (Wharton's jelly) tetraparesis spastica orthopedics 2016 experimental therapy Poland 28,8
198 cord tissue (Wharton's jelly) amyotrophic lateral sclerosis neurology 2016 experimental therapy Poland 60,9
199 cord tissue (Wharton's jelly) spinal muscular atrophy neurology 2016 experimental therapy Poland 34,9
200 cord tissue (Wharton's jelly) gonarthrosis orthopedics 2016 experimental therapy Poland 69,3
201 cord tissue (Wharton's jelly) tetraparesis spastica orthopedics 2016 experimental therapy Poland 47,9
202 cord tissue (Wharton's jelly) spinal cord injury orthopedics 2016 experimental therapy Poland 18,8
203 cord tissue (Wharton's jelly) cerebral palsy neurology 2016 experimental therapy Poland 2,9
204 cord tissue (Wharton's jelly) traumatic brain injury neurology 2016 experimental therapy Poland 54,9
205 cord tissue (Wharton's jelly) epilepsia neurology 2016 experimental therapy Poland 19,5
206 cord tissue (Wharton's jelly) amyotrophic lateral sclerosis neurology 2016 experimental therapy Poland 59
207 cord tissue (Wharton's jelly) amyotrophic lateral sclerosis neurology 2016 experimental therapy Poland 66,9
208 cord tissue (Wharton's jelly) tetraparesis orthopedics 2016 experimental therapy Poland 27,9
209 cord tissue (Wharton's jelly) epilepsia neurology 2016 experimental therapy Poland 14,9
210 cord tissue (Wharton's jelly) amyotrophic lateral sclerosis neurology 2016 experimental therapy Poland 42,7
211 cord tissue (Wharton's jelly) acute graft versus host disease hematology 2016 experimental therapy Poland 60,5
212 cord tissue (Wharton's jelly) autism neurology 2016 experimental therapy Poland 6,2
213 cord tissue (Wharton's jelly) autism neurology 2016 experimental therapy Poland 11,3
214 cord tissue (Wharton's jelly) cerebral palsy neurology 2016 experimental therapy Poland 9,11
215 cord tissue (Wharton's jelly) gonarthrosis orthopedics 2016 experimental therapy Poland 49,8
216 cord tissue (Wharton's jelly) optic atrophy ophthalmology 2016 experimental therapy Poland 69,9
217 cord tissue (Wharton's jelly) optic atrophy ophthalmology 2016 experimental therapy Poland 69,1
218 cord tissue (Wharton's jelly) epilepsia neurology 2016 experimental therapy Poland 13,11
219 cord tissue (Wharton's jelly) amyotrophic lateral sclerosis neurology 2016 experimental therapy Poland 45.1
220 cord tissue (Wharton's jelly) amyotrophic lateral sclerosis neurology 2016 experimental therapy Poland 53.4
221 cord tissue (Wharton's jelly) amyotrophic lateral sclerosis neurology 2016 experimental therapy Poland 36.1
222 cord tissue (Wharton's jelly) amyotrophic lateral sclerosis neurology 2016 experimental therapy Poland 59, 1
223 cord tissue (Wharton's jelly) amyotrophic lateral sclerosis neurology 2016 experimental therapy Poland 66.2
224 cord tissue (Wharton's jelly) amyotrophic lateral sclerosis neurology 2016 experimental therapy Poland 49.7
225 cord tissue (Wharton's jelly) amyotrophic lateral sclerosis neurology 2016 experimental therapy Poland 55.1
226 cord tissue (Wharton's jelly) amyotrophic lateral sclerosis neurology 2016 experimental therapy Poland 46.1
227 cord tissue (Wharton's jelly) amyotrophic lateral sclerosis neurology 2016 experimental therapy Poland 72.4
228 cord tissue (Wharton's jelly) amyotrophic lateral sclerosis neurology 2016 experimental therapy Poland 54.3
229 cord tissue (Wharton's jelly) amyotrophic lateral sclerosis neurology 2016 experimental therapy Poland 56.1
230 cord tissue (Wharton's jelly) amyotrophic lateral sclerosis neurology 2016 experimental therapy Poland 61.8
231 cord tissue (Wharton's jelly) amyotrophic lateral sclerosis neurology 2016 experimental therapy Poland 64.7
232 cord tissue (Wharton's jelly) malformation syndrome neurology 2016 experimental therapy Poland 3,5
233 cord tissue (Wharton's jelly) amyotrophic lateral sclerosis neurology 2016 experimental therapy Poland 64,2
234 cord tissue (Wharton's jelly) retinitis pigmentosa ophthalmology 2016 experimental therapy Poland 38
235 cord tissue (Wharton's jelly) autism neurology 2016 experimental therapy Poland 6,10
236 cord tissue (Wharton's jelly) encephalopathy neurology 2016 experimental therapy Poland 2,11
237 cord tissue (Wharton's jelly) amyotrophic lateral sclerosis neurology 2016 experimental therapy Poland 62,8
238 cord tissue (Wharton's jelly) amyotrophic lateral sclerosis neurology 2016 experimental therapy Poland 56,5
239 cord tissue (Wharton's jelly) amyotrophic lateral sclerosis neurology 2016 experimental therapy Poland 51,3
240 cord tissue (Wharton's jelly) cerebral palsy neurology 2017 experimental therapy Poland 2,10
241 cord tissue (Wharton's jelly) cerebral palsy neurology 2016 experimental therapy Poland 4,2
242 cord tissue (Wharton's jelly) sclerosis multiplex neurology 2016 experimental therapy Poland 55,4
243 cord tissue (Wharton's jelly) sclerosis multiplex neurology 2016 experimental therapy Poland 54,8
244 cord tissue (Wharton's jelly) amyotrophic lateral sclerosis neurology 2016 experimental therapy Poland 33,10
245 cord tissue (Wharton's jelly) sclerosis multiplex neurology 2016 experimental therapy Poland 41,4
246 cord tissue (Wharton's jelly) sclerosis multiplex neurology 2016 experimental therapy Poland 49,3
247 cord tissue (Wharton's jelly) choroideremia ophthalmology 2016 experimental therapy Poland 50,8
248 cord tissue (Wharton's jelly) retinitis pigmentosa ophthalmology 2016 experimental therapy Poland 63,1
249 cord tissue (Wharton's jelly) spinal cord injury orthopedics 2016 experimental therapy Poland 7,4
250 cord tissue (Wharton's jelly) amyotrophic lateral sclerosis neurology 2016 experimental therapy Poland 60,4
251 cord tissue (Wharton's jelly) amyotrophic lateral sclerosis neurology 2016 experimental therapy Poland 73,7
252 cord tissue (Wharton's jelly) leukodystrophy neurology 2016 experimental therapy Poland 2,11
253 cord tissue (Wharton's jelly) amyotrophic lateral sclerosis neurology 2016 experimental therapy Poland 61,6
254 cord tissue (Wharton's jelly) spinal cord injury orthopedics 2016 experimental therapy Poland 48,3
255 cord tissue (Wharton's jelly) retinitis pigmentosa ophthalmology 2016 experimental therapy Poland 32,7
256 cord tissue (Wharton's jelly) acute graft versus host disease hematology 2016 experimental therapy Poland 3,11
257 cord tissue (Wharton's jelly) sclerosis multiplex neurology 2016 experimental therapy Poland 61,11
258 cord tissue (Wharton's jelly) sclerosis multiplex neurology 2016 experimental therapy Poland 45,8
259 cord tissue (Wharton's jelly) amyotrophic lateral sclerosis neurology 2016 experimental therapy Poland 61,4
260 cord tissue (Wharton's jelly) amyotrophic lateral sclerosis neurology 2016 experimental therapy Poland 79,2
261 cord tissue (Wharton's jelly) amyotrophic lateral sclerosis neurology 2016 experimental therapy Poland 72,6
262 cord tissue (Wharton's jelly) amyotrophic lateral sclerosis neurology 2016 experimental therapy Poland 48,4
263 cord tissue (Wharton's jelly) adrenoleukodystrophy neurology 2016 experimental therapy Poland 6,11
264 cord tissue (Wharton's jelly) adrenoleukodystrophy neurology 2016 experimental therapy Poland 9,7
265 cord tissue (Wharton's jelly) amyotrophic lateral sclerosis neurology 2016 experimental therapy Poland 54,2
266 cord tissue (Wharton's jelly) amyotrophic lateral sclerosis neurology 2016 experimental therapy Poland 50,9
267 cord tissue (Wharton's jelly) limb-girdle muscular dystrophy neurology 2016 experimental therapy Poland 22
268 cord tissue (Wharton's jelly) epilepsia neurology 2016 experimental therapy Poland 14,7
269 cord tissue (Wharton's jelly) amyotrophic lateral sclerosis neurology 2016 experimental therapy Poland 55,9
270 cord tissue (Wharton's jelly) amyotrophic lateral sclerosis neurology 2016 experimental therapy Poland 62,6
271 cord tissue (Wharton's jelly) spinal cord injury orthopedics 2016 experimental therapy Poland 58,10
272 cord tissue (Wharton's jelly) cerebral palsy neurology 2016 experimental therapy Poland 12,6
273 cord blood autism neurology 2016 experimental therapy Poland 6
274 cord tissue (Wharton's jelly) amyotrophic lateral sclerosis neurology 2016 experimental therapy Poland 66,2
275 cord tissue (Wharton's jelly) amyotrophic lateral sclerosis neurology 2016 experimental therapy Poland 55,9
276 cord tissue (Wharton's jelly) amyotrophic lateral sclerosis neurology 2016 experimental therapy Poland 49,4
277 cord tissue (Wharton's jelly) amyotrophic lateral sclerosis neurology 2016 experimental therapy Poland 55,7
278 cord tissue (Wharton's jelly) amyotrophic lateral sclerosis neurology 2016 experimental therapy Poland 58.1
279 cord tissue (Wharton's jelly) spina bifida neurology 2016 experimental therapy Poland 4.8
280 cord tissue (Wharton's jelly) spina bifida neurology 2016 experimental therapy Poland 1.5
281 cord tissue (Wharton's jelly) cerebral palsy neurology 2016 experimental therapy Poland 3
282 cord tissue (Wharton's jelly) cerebral palsy neurology 2016 experimental therapy Poland 9.9
283 cord tissue (Wharton's jelly) global developmental delay neurology 2016 experimental therapy Poland 6.9
284 cord tissue (Wharton's jelly) amyotrophic lateral sclerosis neurology 2016 experimental therapy Poland 66.8
285 cord tissue (Wharton's jelly) amyotrophic lateral sclerosis neurology 2016 experimental therapy Poland 39.6
286 cord tissue (Wharton's jelly) autism neurology 2016 experimental therapy Poland 13.2
287 cord tissue (Wharton's jelly) developmental delay neurology 2016 experimental therapy Poland 7.4
288 cord tissue (Wharton's jelly) spina bifida neurology 2016 experimental therapy Poland 7.4
289 cord tissue (Wharton's jelly) optic neuropathy ophthalmology 2016 experimental therapy Poland 66
290 cord tissue (Wharton's jelly) sclerosis multiplex neurology 2016 experimental therapy Poland 38.1
291 cord tissue (Wharton's jelly) autism neurology 2016 experimental therapy Poland 8.4
292 cord tissue (Wharton's jelly) cerebral palsy neurology 2016 experimental therapy Poland 3
293 cord tissue (Wharton's jelly) optic neuropathy ophthalmology 2016 experimental therapy Poland 79,8
294 cord tissue (Wharton's jelly) spinocerebellar ataxia neurology 2016 experimental therapy Poland 54,3
295 cord tissue (Wharton's jelly) dystrophia progressiva pseudohypertrophica /DMD neurology 2016 experimental therapy Poland 14,4
296 cord tissue (Wharton's jelly) amyotrophic lateral sclerosis neurology 2016 experimental therapy Poland 47,11
297 cord tissue (Wharton's jelly) amyotrophic lateral sclerosis neurology 2016 experimental therapy Poland 49,3
298 cord tissue (Wharton's jelly) amyotrophic lateral sclerosis neurology 2016 experimental therapy Poland 61,2
299 cord tissue (Wharton's jelly) retinitis pigmentosa ophthalmology 2016 experimental therapy Poland 23.6
300 cord tissue (Wharton's jelly) age-related macular degeneration ophthalmology 2016 experimental therapy Poland 86.5
301 cord tissue (Wharton's jelly) retinitis pigmentosa ophthalmology 2016 experimental therapy Poland 54.6
302 cord tissue (Wharton's jelly) sclerosis multiplex neurology 2016 experimental therapy Poland 68,5
303 cord tissue (Wharton's jelly) cerebral palsy neurology 2016 experimental therapy Poland 13,7
304 cord tissue (Wharton's jelly) cerebral palsy neurology 2016 experimental therapy Poland 2,2
305 cord tissue (Wharton's jelly) autism neurology 2016 experimental therapy Poland 5,0
306 cord tissue (Wharton's jelly) cerebral palsy neurology 2016 experimental therapy Poland 12,11
307 cord tissue (Wharton's jelly) autism neurology 2016 experimental therapy Poland 12,3
308 cord tissue (Wharton's jelly) spina bifida neurology 2016 experimental therapy Poland 1,3
309 cord tissue (Wharton's jelly) developmental delay neurology 2016 experimental therapy Poland 2,7
310 cord tissue (Wharton's jelly) spinal muscular atrophy neurology 2016 experimental therapy Poland 3,3
311 cord tissue (Wharton's jelly) facio-scapulo-humeral muscular dystrophy neurology 2016 experimental therapy Poland 59,6
312 cord tissue (Wharton's jelly) spinal muscular atrophy neurology 2016 experimental therapy Poland 34,2
313 cord tissue (Wharton's jelly) muscular dystrophy neurology 2016 experimental therapy Poland 30,3
314 cord tissue (Wharton's jelly) spinal muscular atrophy neurology 2016 experimental therapy Poland 17,10
315 cord tissue (Wharton's jelly) spinal cord injury orthopedics 2016 experimental therapy Poland 37,11
316 cord tissue (Wharton's jelly) amyotrophic lateral sclerosis neurology 2016 experimental therapy Poland 31,9
317 cord tissue (Wharton's jelly) ataxia hereditaria neurology 2016 experimental therapy Poland 69
318 cord tissue (Wharton's jelly) muscular dystrophy neurology 2016 experimental therapy Poland 31,9
319 cord tissue (Wharton's jelly) no data ophthalmology 2016 experimental therapy Poland 66,1
320 cord tissue (Wharton's jelly) amyotrophic lateral sclerosis neurology 2016 experimental therapy Poland 53,4
321 cord tissue (Wharton's jelly) patella cartilage damage orthopedics 2016 experimental therapy Poland 60,8
322 cord tissue (Wharton's jelly) cerebral palsy neurology 2016 experimental therapy Poland 10,8
323 cord tissue (Wharton's jelly) encephalopathy neurology 2016 experimental therapy Poland 3
324 cord tissue (Wharton's jelly) spina bifida neurology 2016 experimental therapy Poland 2,11
325 cord tissue (Wharton's jelly) encephalopathy neurology 2016 experimental therapy Poland 4,3
326 cord tissue (Wharton's jelly) retinitis pigmentosa ophthalmology 2016 experimental therapy Poland n/a
327 cord tissue (Wharton's jelly) retinitis pigmentosa ophthalmology 2016 experimental therapy Poland 59,4
328 cord tissue (Wharton's jelly) atrophy of the optic nerves ophthalmology 2016 experimental therapy Poland 20,11
329 cord tissue (Wharton's jelly) patella cartilage damage orthopedics 2016 experimental therapy Poland 53
330 cord tissue (Wharton's jelly) autism neurology 2016 experimental therapy Poland 24,5
331 cord tissue (Wharton's jelly) dystrophia progressiva pseudohypertrophica /DMD neurology 2016 experimental therapy Poland 34, 7
332 cord tissue (Wharton's jelly) muscular dystrophy neurology 2016 experimental therapy Poland 32,3
333 cord tissue (Wharton's jelly) amyotrophic lateral sclerosis neurology 2016 experimental therapy Poland 65,9
334 cord tissue (Wharton's jelly) amyotrophic lateral sclerosis neurology 2016 experimental therapy Poland 52,7
335 cord tissue (Wharton's jelly) amyotrophic lateral sclerosis neurology 2016 experimental therapy Poland 71,5
336 cord tissue (Wharton's jelly) retinitis pigmentosa ophthalmology 2016 experimental therapy Poland 60,7
337 cord tissue (Wharton's jelly) cerebral palsy neurology 2016 experimental therapy Poland 1,10
338 cord tissue (Wharton's jelly) cerebral palsy neurology 2016 experimental therapy Poland 7,6
339 cord tissue (Wharton's jelly) spinal muscular atrophy neurology 2016 experimental therapy Poland 1,10
340 cord tissue (Wharton's jelly) spinal cord injury orthopedics 2016 experimental therapy Poland 29,7
341 cord tissue (Wharton's jelly) amyotrophic lateral sclerosis neurology 2016 experimental therapy Poland 68,5
342 cord tissue (Wharton's jelly) chronic graft versus host disease hematology 2016 experimental therapy Poland 8/12
343 cord tissue (Wharton's jelly) amyotrophic lateral sclerosis neurology 2016 experimental therapy Poland 44,5
344 cord tissue (Wharton's jelly) dystrophia progressiva pseudohypertrophica /DMD neurology 2016 experimental therapy Poland 9,2
345 cord tissue (Wharton's jelly) Stargardt's disease ophthalmology 2016 experimental therapy Poland 24,5
346 cord tissue (Wharton's jelly) amyotrophic lateral sclerosis neurology 2016 experimental therapy Poland 66,7
347 cord tissue (Wharton's jelly) spina bifida neurology 2016 experimental therapy Poland 15,9
348 cord tissue (Wharton's jelly) cerebral palsy neurology 2016 experimental therapy Poland 6,8
349 cord tissue (Wharton's jelly) autism neurology 2016 experimental therapy Poland 10,3
350 cord tissue (Wharton's jelly) cerebral palsy neurology 2016 experimental therapy Poland 16,4
351 cord tissue (Wharton's jelly) autism neurology 2016 experimental therapy Poland 6
352 cord tissue (Wharton's jelly) spinocerebellar ataxia neurology 2016 experimental therapy Poland 41,8
353 cord tissue (Wharton's jelly) amyotrophic lateral sclerosis neurology 2016 experimental therapy Poland 51,9
354 cord tissue (Wharton's jelly) amyotrophic lateral sclerosis neurology 2016 experimental therapy Poland 49,3
355 cord tissue (Wharton's jelly) autism neurology 2016 experimental therapy Poland 20,9
356 cord tissue (Wharton's jelly) fetal alcohol spectrum disorders neurology 2016 experimental therapy Poland 5,2
357 cord tissue (Wharton's jelly) cerebral palsy neurology 2016 experimental therapy Poland 13,10
358 cord tissue (Wharton's jelly) tetraparesis spastica orthopedics 2016 experimental therapy Poland 58,4
359 cord tissue (Wharton's jelly) amyotrophic lateral sclerosis neurology 2016 experimental therapy Poland 68,2
360 cord tissue (Wharton's jelly) chondronecrosis femoral condyle orthopedics 2016 experimental therapy Poland 54,11
361 cord tissue (Wharton's jelly) amyotrophic lateral sclerosis neurology 2016 experimental therapy Poland 55.4
362 cord tissue (Wharton's jelly) amyotrophic lateral sclerosis neurology 2016 experimental therapy Poland 41.2
363 cord tissue (Wharton's jelly) amyotrophic lateral sclerosis neurology 2016 experimental therapy Poland 72.1
364 cord tissue (Wharton's jelly) amyotrophic lateral sclerosis neurology 2016 experimental therapy Poland 56.8
365 cord tissue (Wharton's jelly) spina bifida neurology 2016 experimental therapy Poland 2.11
366 cord tissue (Wharton's jelly) tetraparesis spastica orthopedics 2016 experimental therapy Poland 18
367 cord tissue (Wharton's jelly) cerebral palsy neurology 2016 experimental therapy Poland 4,1
368 cord blood acute lymphoblastic leukemia hematology 2016 standard therapy Hungary 7
369 cord tissue (Wharton's jelly) amyotrophic lateral sclerosis neurology 2016 experimental therapy Poland 48,1
370 cord tissue (Wharton's jelly) amyotrophic lateral sclerosis neurology 2016 experimental therapy Poland 56,3
371 cord tissue (Wharton's jelly) amyotrophic lateral sclerosis neurology 2016 experimental therapy Poland 66,10
372 cord tissue (Wharton's jelly) amyotrophic lateral sclerosis neurology 2016 experimental therapy Poland n/a
373 cord tissue (Wharton's jelly) gangliosidosis t. 1 neurology 2016 experimental therapy Poland 1,4
374 cord tissue (Wharton's jelly) epilepsia neurology 2016 experimental therapy Poland 14.9
375 cord tissue (Wharton's jelly) epileptic encephalopathy neurology 2016 experimental therapy Poland 3.6
376 cord tissue (Wharton's jelly) polineuropathy neurology 2016 experimental therapy Poland 70.8
377 cord tissue (Wharton's jelly) diffuse cartilage damage left medial compartment of the knee orthopedics 2016 experimental therapy Poland 50,5
378 cord tissue (Wharton's jelly) Stargardt's disease ophthalmology 2016 experimental therapy Poland 37,7
379 cord tissue (Wharton's jelly) myopia, hyperopia, astigmatism, abnormal refraction and accommodation, optic atrophy ophthalmology 2016 experimental therapy Poland 37,1
380 cord tissue (Wharton's jelly) optic neuropathy ophthalmology 2016 experimental therapy Poland 33,5
381 cord tissue (Wharton's jelly) epilepsia neurology 2016 experimental therapy Poland 16,2
382 cord tissue (Wharton's jelly) cerebral palsy neurology 2016 experimental therapy Poland 3,7
383 cord tissue (Wharton's jelly) spinal cord injury orthopedics 2016 experimental therapy Poland 17,9
384 cord tissue (Wharton's jelly) injuries to the spinal nerves neurology 2016 experimental therapy Poland 5/12
385 cord tissue (Wharton's jelly) cartilage damage orthopedics 2016 experimental therapy Poland 57,6
386 cord tissue (Wharton's jelly) dystrophia progressiva pseudohypertrophica /DMD neurology 2016 experimental therapy Poland 4,8
387 cord tissue (Wharton's jelly) muscular dystrophy neurology 2016 experimental therapy Poland 44,7
388 cord tissue (Wharton's jelly) dystrophia progressiva pseudohypertrophica /DMD neurology 2016 experimental therapy Poland 10
389 cord tissue (Wharton's jelly) cerebral palsy neurology 2016 experimental therapy Poland 4,4
390 cord tissue (Wharton's jelly) spina bifida neurology 2016 experimental therapy Poland 4,9
391 cord tissue (Wharton's jelly) cerebellar syndrome neurology 2016 experimental therapy Poland 28,6
392 cord tissue (Wharton's jelly) neurodevelopmental disorders neurology 2016 experimental therapy Poland 4,5
393 cord tissue (Wharton's jelly) tetraparesis orthopedics 2016 experimental therapy Poland 27,2
394 cord tissue (Wharton's jelly) amyotrophic lateral sclerosis neurology 2016 experimental therapy Poland 61,2
395 cord tissue (Wharton's jelly) retinitis pigmentosa ophthalmology 2016 experimental therapy Poland 44,8
396 cord tissue (Wharton's jelly) degeneration of the cartilage of the knee joint orthopedics 2016 experimental therapy Poland 54,3
397 cord tissue (Wharton's jelly) dystrophia progressiva pseudohypertrophica /BMD neurology 2016 experimental therapy Poland 19,2
398 cord tissue (Wharton's jelly) facio-scapulo-humeral muscular dystrophy neurology 2016 experimental therapy Poland 15,0
399 cord tissue (Wharton's jelly) facio-scapulo-humeral muscular dystrophy neurology 2016 experimental therapy Poland 31,11
400 cord tissue (Wharton's jelly) facio-scapulo-humeral muscular dystrophy neurology 2016 experimental therapy Poland 33,4
401 cord tissue (Wharton's jelly) endometrial atrophy ginecology 2016 experimental therapy Poland 37,3
402 cord tissue (Wharton's jelly) endometrial atrophy ginecology 2016 experimental therapy Poland 39,1
403 cord tissue (Wharton's jelly) sclerosis multiplex neurology 2016 experimental therapy Poland 38,4
404 cord tissue (Wharton's jelly) spinal cord injury neurology 2016 experimental therapy Poland 44,5
405 cord tissue (Wharton's jelly) meniscus damage orthopedics 2016 experimental therapy Poland 35,5
406 cord tissue (Wharton's jelly) amyotrophic lateral sclerosis neurology 2016 experimental therapy Poland 60,8
407 cord tissue (Wharton's jelly) premature ovarian failure ginecology 2016 experimental therapy Poland 23,4
408 cord tissue (Wharton's jelly) premature ovarian failure ginecology 2016 experimental therapy Poland 34,9
409 cord tissue (Wharton's jelly) amyotrophic lateral sclerosis neurology 2016 experimental therapy Poland 55,5
410 cord tissue (Wharton's jelly) amyotrophic lateral sclerosis neurology 2017 experimental therapy Poland 67,11
411 cord tissue (Wharton's jelly) amyotrophic lateral sclerosis neurology 2017 experimental therapy Poland 37,9
412 cord tissue (Wharton's jelly) amyotrophic lateral sclerosis neurology 2017 experimental therapy Poland 71,7
413 cord tissue (Wharton's jelly) amyotrophic lateral sclerosis neurology 2017 experimental therapy Poland n/a
414 cord tissue (Wharton's jelly) autism neurology 2017 experimental therapy Poland 7,11
415 cord tissue (Wharton's jelly) amyotrophic lateral sclerosis neurology 2017 experimental therapy Poland 47,6
416 cord tissue (Wharton's jelly) spinocerebellar ataxia neurology 2017 experimental therapy Poland 44,1
417 cord tissue (Wharton's jelly) spinal cord injury orthopedics 2017 experimental therapy Poland 34,11
418 cord tissue (Wharton's jelly) retinitis pigmentosa ophthalmology 2017 experimental therapy Poland 58,10
419 cord tissue (Wharton's jelly) retinitis pigmentosa ophthalmology 2017 experimental therapy Poland 49
420 cord tissue (Wharton's jelly) Stargardt's disease ophthalmology 2017 experimental therapy Poland 37,4
421 cord tissue (Wharton's jelly) muscular dystrophy neurology 2017 experimental therapy Poland 37,7
422 cord tissue (Wharton's jelly) muscular dystrophy neurology 2017 experimental therapy Poland 26,11
423 cord tissue (Wharton's jelly) amyotrophic lateral sclerosis neurology 2017 experimental therapy Poland 56,7
424 cord tissue (Wharton's jelly) amyotrophic lateral sclerosis neurology 2017 experimental therapy Poland 48,11
425 cord tissue (Wharton's jelly) amyotrophic lateral sclerosis neurology 2017 experimental therapy Poland 46,3
426 cord tissue (Wharton's jelly) cartilage damage orthopedics 2017 experimental therapy Poland 61,5
427 cord tissue (Wharton's jelly) spinal cord injury neurology 2017 experimental therapy Poland 34,1
428 cord tissue (Wharton's jelly) sclerosis multiplex neurology 2017 experimental therapy Poland 52,9
429 cord tissue (Wharton's jelly) atrophy of the optic nerves ophthalmology 2017 experimental therapy Poland 23,9
430 cord tissue (Wharton's jelly) Stargardt's disease ophthalmology 2017 experimental therapy Poland 31,6
431 cord tissue (Wharton's jelly) age-related macular degeneration ophthalmology 2017 experimental therapy Poland 33,4
432 peripheral blood acute myelogenous leukemia hematology 2016 standard therapy United Kingdom 58
433 peripheral blood acute lymphoblastic leukemia hematology 2016 standard therapy Poland 56
434 bone marrow osteopetrosis metabolic 2016 standard therapy Russia 6
435 bone marrow severe combined immunodeficiency hematology 2016 standard therapy Romania 2
436 peripheral blood myelodysplastic syndrome hematology 2016 standard therapy Austria 60
437 peripheral blood acute myelogenous leukemia hematology 2016 standard therapy Australia 62
438 peripheral blood no data n/a 2016 standard therapy Czech Republic 45
439 peripheral blood chronic lymphocytic leukemia hematology 2016 standard therapy Slovakia 52
440 peripheral blood acute myelogenous leukemia hematology 2016 standard therapy France 40
441 peripheral blood no data n/a 2016 standard therapy Netherlands 70
442 peripheral blood no data n/a 2016 standard therapy Poland 43
443 peripheral blood acute myelogenous leukemia hematology 2016 standard therapy Poland 18
444 peripheral blood X-linked lymphoproliferative disease hematology 2016 standard therapy Russia 12
445 peripheral blood chronic lymphocytic leukemia hematology 2016 standard therapy Sweden 61
446 peripheral blood acute myelogenous leukemia hematology 2016 standard therapy Germany 66
447 peripheral blood no data n/a 2016 standard therapy Netherlands 69
448 peripheral blood acute lymphoblastic leukemia hematology 2016 standard therapy Columbia 43
449 peripheral blood acute myelogenous leukemia hematology 2016 standard therapy Germany 64
450 peripheral blood Hodgkin’s lymphoma hematology 2016 standard therapy Poland 31
451 peripheral blood acute myelogenous leukemia hematology 2016 standard therapy Czech Republic 54
452 peripheral blood T-cell leukemia/lymphoma hematology 2016 standard therapy Canada 31
453 bone marrow T-cell acute lymphoblastic leukemia hematology 2016 standard therapy Italy 4
454 peripheral blood acute myelogenous leukemia hematology 2016 standard therapy Poland 54
455 peripheral blood primary myelofibrosis hematology 2016 standard therapy Germany 50
456 peripheral blood acute myelogenous leukemia hematology 2016 standard therapy Poland 18
457 peripheral blood adrenoleukodystrophy metabolic 2016 standard therapy Poland 1
458 peripheral blood acute myelogenous leukemia hematology 2016 standard therapy Italy 31
459 peripheral blood no data n/a 2016 standard therapy Poland 28
460 peripheral blood acute myelogenous leukemia hematology 2016 standard therapy Sweden 35
461 bone marrow no data n/a 2016 standard therapy Italy 3
462 bone marrow acute myelogenous leukemia hematology 2016 standard therapy Italy 64
463 peripheral blood no data n/a 2016 standard therapy Czech Republic 1
464 peripheral blood Wiskott-Aldrich syndrome hematology 2016 standard therapy Poland 1
465 peripheral blood no data n/a 2016 standard therapy Belgium 30
466 bone marrow acute lymphoblastic leukemia hematology 2016 standard therapy Italy 9
467 bone marrow acute myelogenous leukemia hematology 2016 standard therapy Spain 55
468 bone marrow Fanconi anaemia hematology 2016 standard therapy Estonia 7
469 peripheral blood no data n/a 2016 standard therapy Germany 71
470 peripheral blood acute myelogenous leukemia hematology 2016 standard therapy Germany 46
471 peripheral blood acute myelogenous leukemia hematology 2016 standard therapy Germany 29
472 peripheral blood myelodysplastic syndrome hematology 2016 standard therapy Czech Republic 56
473 bone marrow acute lymphoblastic leukemia hematology 2016 standard therapy Italy 6
474 bone marrow acute myelogenous leukemia hematology 2016 standard therapy Italy 64
475 peripheral blood acute myelogenous leukemia hematology 2016 standard therapy France 32
476 peripheral blood acute myelogenous leukemia hematology 2016 standard therapy Czech Republic 49
477 peripheral blood myelodysplastic syndrome hematology 2016 standard therapy Germany 50
478 peripheral blood acute myelogenous leukemia hematology 2016 standard therapy Poland 64
479 peripheral blood acute myelogenous leukemia hematology 2016 standard therapy Poland 42
480 peripheral blood acute myelogenous leukemia hematology 2016 standard therapy Germany 13
481 peripheral blood acute myelogenous leukemia hematology 2016 standard therapy Slovakia 8
482 peripheral blood acute myelogenous leukemia hematology 2016 standard therapy Belgium 46
483 peripheral blood refractory anemia with excess blasts hematology 2016 standard therapy United Kingdom 62
484 bone marrow acute lymphoblastic leukemia hematology 2016 standard therapy Italy 14
485 peripheral blood acute myelogenous leukemia hematology 2016 standard therapy Poland 40
486 peripheral blood myelodysplastic syndrome - RAEB hematology 2016 standard therapy Poland 56
487 peripheral blood no data n/a 2016 standard therapy Sweden 58
488 peripheral blood Hodgkin’s lymphoma hematology 2016 standard therapy Germany 32
489 peripheral blood acute myelogenous leukemia hematology 2016 standard therapy Germany 32
490 peripheral blood acute myelogenous leukemia hematology 2016 standard therapy Germany 66
491 peripheral blood T Cell Lymphoma/ NOS - Not otherwise specified hematology 2016 standard therapy Germany 55
492 bone marrow biphenotypic leukemia hematology 2016 standard therapy Brazil 27
493 peripheral blood acute myelogenous leukemia hematology 2016 standard therapy Germany 43
494 bone marrow acute lymphoblastic leukemia hematology 2016 standard therapy Germany 7
495 peripheral blood no data n/a 2016 standard therapy Czech Republic 59
496 peripheral blood aplastic anaemia hematology 2016 standard therapy United Kingdom 23
497 peripheral blood myelodysplastic syndrome hematology 2016 standard therapy Germany 73
498 peripheral blood myelofibrosis hematology 2016 standard therapy Israel 72
499 peripheral blood acute lymphoblastic leukemia hematology 2016 standard therapy Australia 61
500 bone marrow osteopetrosis metabolic 2016 standard therapy Germany 1
501 peripheral blood primary myelofibrosis hematology 2016 standard therapy Germany 67
502 peripheral blood myelodysplastic syndrome hematology 2016 standard therapy Ireland 47
503 peripheral blood no data n/a 2016 standard therapy Germany 17
504 peripheral blood no data n/a 2016 standard therapy France 59
505 peripheral blood acute myelogenous leukemia hematology 2016 standard therapy Germany 66
506 peripheral blood chronic lymphocytic leukemia hematology 2016 standard therapy Germany 62
507 peripheral blood acute myelogenous leukemia hematology 2016 standard therapy France 47
508 peripheral blood myelodysplastic syndrome hematology 2016 standard therapy France 67
509 peripheral blood acute myelogenous leukemia hematology 2016 standard therapy Lithuania 15
510 peripheral blood Hodgkin’s lymphoma hematology 2016 standard therapy United Kingdom 18
511 peripheral blood acute myelogenous leukemia hematology 2016 standard therapy Czech Republic 37
512 peripheral blood acute lymphoblastic leukemia hematology 2016 standard therapy France 24
513 bone marrow severe aplastic anaemia hematology 2016 standard therapy France 9
514 bone marrow no data n/a 2016 standard therapy Poland 7
515 peripheral blood acute lymphoblastic leukemia hematology 2016 standard therapy Canada 13
516 peripheral blood acute myelogenous leukemia hematology 2016 standard therapy Hungary 57
517 peripheral blood acute myelogenous leukemia hematology 2016 standard therapy Belgium 56
518 bone marrow Hurler syndrome metabolic 2016 standard therapy United Kingdom 2
519 peripheral blood acute myelogenous leukemia hematology 2016 standard therapy France 38
520 peripheral blood acute myelogenous leukemia hematology 2016 standard therapy France 52
521 peripheral blood chronic myelomonocytic leukemia, minimal residual disease hematology 2016 standard therapy Poland 50
522 peripheral blood myeloma multiplex hematology 2016 standard therapy Germany 63
523 peripheral blood Fanconi anaemia hematology 2016 standard therapy Estonia 7
524 peripheral blood plasma cell disorder hematology 2016 standard therapy France 47
525 peripheral blood acute myelogenous leukemia hematology 2016 standard therapy Germany 35
526 peripheral blood acute myelogenous leukemia hematology 2016 standard therapy Germany 72
527 peripheral blood myeloma multiplex hematology 2016 standard therapy Poland 51
528 peripheral blood acute lymphoblastic leukemia hematology 2016 standard therapy Spain 58
529 bone marrow  severe combined immunodeficiency hematology 2016 standard therapy Turkey 4
530 peripheral blood myelodysplastic syndrome hematology 2016 standard therapy Estonia 62
531 peripheral blood acute myelogenous leukemia hematology 2016 standard therapy Hungary 46
532 peripheral blood acute lymphoblastic leukemia hematology 2016 standard therapy Hungary 20
533 peripheral blood acute myelogenous leukemia hematology 2016 standard therapy Italy 51
534 peripheral blood primary Immunodeficiency hematology 2016 standard therapy Russia 5
535 peripheral blood acute myelogenous leukemia hematology 2016 standard therapy United Kingdom 62
536 peripheral blood acute myelogenous leukemia hematology 2016 standard therapy Germany 69
537 bone marrow acute lymphoblastic leukemia hematology 2016 standard therapy Canada 11
538 peripheral blood acute myelogenous leukemia hematology 2016 standard therapy Australia 51
539 peripheral blood no data n/a 2016 standard therapy Netherlands 58
540 peripheral blood acute myelogenous leukemia hematology 2016 standard therapy Spain 38
541 peripheral blood acute lymphoblastic leukemia hematology 2016 standard therapy Lithuania 23
542 peripheral blood chronic myeloid leukemia hematology 2016 standard therapy Germany 62
543 peripheral blood Hodgkin’s lymphoma hematology 2016 standard therapy Germany 32
544 bone marrow myelofibrosis hematology 2016 standard therapy Germany 31
545 bone marrow DiGeorge syndrome hematology 2016 standard therapy Netherlands 24
546 peripheral blood acute lymphoblastic leukemia hematology 2016 standard therapy Germany 27
547 peripheral blood acute lymphoblastic leukemia hematology 2016 standard therapy Poland 30
548 peripheral blood acute myelogenous leukemia hematology 2016 standard therapy Turkey 55
549 peripheral blood acute myelogenous leukemia hematology 2016 standard therapy Israel 63
550 peripheral blood acute lymphoblastic leukemia hematology 2016 standard therapy Turkey 37
551 peripheral blood acute myelogenous leukemia hematology 2016 standard therapy Germany 66
552 peripheral blood acute lymphoblastic leukemia hematology 2016 standard therapy Turkey 38
553 peripheral blood acute myelogenous leukemia hematology 2016 standard therapy Germany 65
554 bone marrow Hodgkin’s lymphoma hematology 2016 standard therapy Italy 17
555 peripheral blood acute myelogenous leukemia hematology 2016 standard therapy Poland 46
556 bone marrow acute myelogenous leukemia hematology 2016 standard therapy Belarus 12
557 peripheral blood acute myelogenous leukemia hematology 2016 standard therapy Germany 18
558 bone marrow acute lymphoblastic leukemia hematology 2016 standard therapy Belarus 18
559 peripheral blood Hodgkin’s lymphoma hematology 2016 standard therapy Netherlands 38
560 peripheral blood acute myelogenous leukemia hematology 2016 standard therapy Turkey 48
561 peripheral blood myelodysplastic syndrome hematology 2016 standard therapy Germany 61
562 peripheral blood acute myelogenous leukemia hematology 2016 standard therapy France 67
563 peripheral blood no data n/a 2016 standard therapy Poland 55
564 bone marrow severe combined immunodeficiency hematology 2016 standard therapy Poland 7 3/25
565 peripheral blood acute myelogenous leukemia hematology 2016 standard therapy France 32
566 peripheral blood T-cell acute lymphoblastic leukemia hematology 2016 standard therapy Germany 19
567 peripheral blood myelodysplastic syndrome hematology 2016 standard therapy United Kingdom 68
568 peripheral blood acute myelogenous leukemia hematology 2016 standard therapy Germany 59
569 peripheral blood myelodysplastic syndrome - RCMD hematology 2016 standard therapy Czech Republic 32
570 peripheral blood myelodysplastic syndrome hematology 2016 standard therapy Belgium 65
571 peripheral blood myelofibrosis hematology 2016 standard therapy Netherlands 66
572 peripheral blood acute myelogenous leukemia hematology 2016 standard therapy Switzerland 8/12
573 peripheral blood acute myelogenous leukemia hematology 2016 standard therapy Israel 36
574 peripheral blood acute myelogenous leukemia hematology 2016 standard therapy Germany 66
575 bone marrow severe aplastic anaemia hematology 2016 standard therapy France 9
576 bone marrow severe aplastic anaemia / paroxymal nocturnal haemoglobinuria hematology 2016 standard therapy Poland 17
577 bone marrow myelodysplastic syndrome hematology 2016 standard therapy Hungary 1
578 bone marrow acute myelogenous leukemia hematology 2016 standard therapy Italy 67
579 bone marrow myelodysplastic syndrome hematology 2016 standard therapy Spain 56
580 peripheral blood acute myelogenous leukemia hematology 2016 standard therapy Denmark 68
581 peripheral blood myelodysplastic syndrome hematology 2016 standard therapy Spain 15
582 bone marrow Fanconi anaemia hematology 2016 standard therapy Netherlands 41
583 peripheral blood myelodysplastic syndrome hematology 2016 standard therapy Italy 52
584 peripheral blood chronic myelomonocytic leukaemia hematology 2016 standard therapy Finland 53
585 peripheral blood no data n/a 2016 standard therapy Turkey 4
586 peripheral blood leukemia hematology 2016 standard therapy Lithuania 53
587 peripheral blood T-cell acute lymphoblastic leukemia hematology 2016 standard therapy Serbia 21
588 peripheral blood myeloproliferative syndrome hematology 2016 standard therapy Poland 52
589 peripheral blood acute myelogenous leukemia hematology 2016 standard therapy France 63
590 peripheral blood no data n/a 2016 standard therapy Poland 44
591 bone marrow acute lymphoblastic leukemia hematology 2016 standard therapy France 5
592 peripheral blood acute myelogenous leukemia hematology 2016 standard therapy Czech Republic 60
593 peripheral blood T-cell acute lymphoblastic leukemia hematology 2016 standard therapy Austria 41
594 peripheral blood primary myelofibrosis hematology 2016 standard therapy Switzerland 67
595 peripheral blood myelodysplastic syndrome hematology 2016 standard therapy United Kingdom 20
596 peripheral blood acute myelogenous leukemia hematology 2016 standard therapy Brazil 37
597 bone marrow acute myelogenous leukemia hematology 2016 standard therapy United Kingdom 29
598 peripheral blood myelodysplastic syndrome hematology 2016 standard therapy France 60
599 peripheral blood acute myelogenous leukemia hematology 2016 standard therapy Germany 61
600 peripheral blood acute myelogenous leukemia hematology 2016 standard therapy Turkey 51
601 bone marrow acute lymphoblastic leukemia hematology 2016 standard therapy Belarus 25
602 peripheral blood acute lymphoblastic leukemia hematology 2016 standard therapy France 28
603 bone marrow acute lymphoblastic leukemia hematology 2016 standard therapy New Zealand 1
604 bone marrow severe combined immunodeficiency hematology 2016 standard therapy Germany 12
605 bone marrow acute lymphoblastic leukemia hematology 2016 standard therapy Poland 5
606 peripheral blood acute myelogenous leukemia hematology 2016 standard therapy Poland 65
607 peripheral blood acute myelogenous leukemia hematology 2016 standard therapy Italy 53
608 peripheral blood Lymphoblastic Lymphoma hematology 2016 standard therapy Italy 33
609 peripheral blood acute lymphoblastic leukemia hematology 2016 standard therapy Slovakia 30
610 peripheral blood myelodysplastic syndrome hematology 2016 standard therapy Belgium 9
611 peripheral blood myeloma multiplex hematology 2016 standard therapy Poland 38
612 peripheral blood acute lymphoblastic leukemia hematology 2016 standard therapy Poland 39
613 peripheral blood myelodysplastic syndrome hematology 2016 standard therapy Austria 61
614 peripheral blood acute myelogenous leukemia hematology 2016 standard therapy New Zealand 59
615 peripheral blood acute myelogenous leukemia hematology 2016 standard therapy Australia 62
616 peripheral blood acute myelogenous leukemia hematology 2016 standard therapy Germany 65
617 peripheral blood acute myelogenous leukemia hematology 2016 standard therapy Portugal 41
618 peripheral blood myelodysplastic syndrome hematology 2016 standard therapy France 59
619 peripheral blood SAA / Amyloidosis hematology 2016 standard therapy United Kingdom 45
620 peripheral blood chronic myeloid leukemia hematology 2016 standard therapy Finland 46
621 peripheral blood acute myelogenous leukemia hematology 2016 standard therapy Poland 50
622 bone marrow no data n/a 2016 standard therapy Poland 33
623 peripheral blood acute lymphoblastic leukemia hematology 2016 standard therapy Italy 66
624 peripheral blood non-Hodgkin lymphoma hematology 2016 standard therapy Russia 38
625 peripheral blood acute lymphoblastic leukemia hematology 2016 standard therapy Poland 20
626 peripheral blood myelofibrosis hematology 2016 standard therapy France 67
627 peripheral blood B-cell Acute lymphoblastic leukemia hematology 2016 standard therapy Belgium 44
628 peripheral blood non-Hodgkin lymphoma hematology 2016 standard therapy Poland 58
629 peripheral blood acute myelogenous leukemia hematology 2016 standard therapy Germany 72
630 bone marrow non-Hodgkin lymphoma hematology 2016 standard therapy Italy 46
631 peripheral blood acute myelogenous leukemia hematology 2016 standard therapy United Kingdom 68
632 peripheral blood myelodysplastic syndrome hematology 2016 standard therapy Germany 63
633 peripheral blood acute lymphoblastic leukemia hematology 2016 standard therapy France 56
634 peripheral blood acute myelogenous leukemia hematology 2016 standard therapy Poland 54
635 bone marrow aplastic anaemia hematology 2016 standard therapy Austria 20
636 peripheral blood acute myelogenous leukemia hematology 2016 standard therapy Poland 24
637 peripheral blood acute lymphoblastic leukemia hematology 2016 standard therapy Greece 9
638 bone marrow acute myelogenous leukemia hematology 2016 standard therapy Croatia 33
639 bone marrow myeloproliferative syndrome hematology 2016 standard therapy Poland 22
640 peripheral blood chronic myeloid leukemia hematology 2016 standard therapy Germany 40
641 peripheral blood myelodysplastic syndrome hematology 2016 standard therapy Germany 15
642 peripheral blood myelodysplastic syndrome hematology 2016 standard therapy Germany 37
643 bone marrow acute myelogenous leukemia hematology 2016 standard therapy Ireland 39
644 peripheral blood acute myelogenous leukemia hematology 2016 standard therapy Russia 44
645 bone marrow Diamond-Balckfan anaemia hematology 2016 standard therapy Germany 2
646 peripheral blood myelodysplastic syndrome hematology 2016 standard therapy Germany 5 9
647 peripheral blood non-Hodgkin lymphoma hematology 2016 standard therapy Russia 32
648 peripheral blood myelodysplastic syndrome hematology 2016 standard therapy Germany 62
649 peripheral blood acute myelogenous leukemia hematology 2016 standard therapy Poland 55
650 bone marrow acute myelogenous leukemia hematology 2016 standard therapy Czech Republic 9
651 peripheral blood composite lymphoma hematology 2016 standard therapy Germany 51
652 peripheral blood acute myelogenous leukemia hematology 2016 standard therapy Italy 30
653 peripheral blood acute lymphoblastic leukemia hematology 2016 standard therapy Germany 33
654 bone marrow acute lymphoblastic leukemia hematology 2016 standard therapy Belarus 15
655 peripheral blood myelodysplastic syndrome hematology 2016 standard therapy Italy 58
656 peripheral blood high-risk acute lymphoblastic leukemia hematology 2016 standard therapy Poland 5
657 peripheral blood acute myelogenous leukemia M2/M4 hematology 2016 standard therapy Germany 59
658 bone marrow juvenile myelomonocytic leukemia hematology 2016 standard therapy Germany 3
659 peripheral blood non-Hodgkin lymphoma hematology 2016 standard therapy Netherlands 39
660 peripheral blood acute lymphoblastic leukemia hematology 2016 standard therapy Italy 21
661 peripheral blood acute myelogenous leukemia hematology 2016 standard therapy Spain 50
662 bone marrow acute myelogenous leukemia hematology 2016 standard therapy Finland 45
663 bone marrow anaemia hematology 2016 standard therapy Germany 16
664 peripheral blood plasma cell disorder hematology 2016 standard therapy France 54
665 peripheral blood acute myelogenous leukemia hematology 2016 standard therapy United Kingdom 47
666 peripheral blood acute myelogenous leukemia hematology 2016 standard therapy Canada 47
667 peripheral blood myelodysplastic syndrome hematology 2016 standard therapy Germany 67
668 peripheral blood myelodysplastic syndrome hematology 2016 standard therapy Germany 62
669 bone marrow acute lymphoblastic leukemia hematology 2016 standard therapy Germany 6
670 bone marrow anaemia hematology 2016 standard therapy Italy 5
671 bone marrow high-risk acute lymphoblastic leukemia hematology 2016 standard therapy Poland 18
672 peripheral blood acute myelogenous leukemia hematology 2016 standard therapy Italy 63
673 peripheral blood acute myelogenous leukemia hematology 2016 standard therapy Poland 19
674 peripheral blood T-cell-prolymphocytic leukemia hematology 2016 standard therapy United Kingdom 61
675 peripheral blood myelodysplastic syndrome hematology 2016 standard therapy USA 69
676 peripheral blood acute lymphoblastic leukemia hematology 2016 standard therapy France 35
677 peripheral blood severe aplastic anaemia hematology 2016 standard therapy Russia 18
678 peripheral blood myelodysplastic syndrome hematology 2016 standard therapy Germany 66
679 peripheral blood Hurler syndrome hematology 2017 standard therapy United Kingdom 2
680 bone marrow acute lymphoblastic leukemia hematology 2017 standard therapy Poland 6
681 peripheral blood myeloma multiplex hematology 2017 standard therapy Germany 44
682 peripheral blood myelodysplastic syndrome hematology 2017 standard therapy Poland 60
683 bone marrow acute myelogenous leukemia hematology 2017 standard therapy Germany 76
684 bone marrow acute myelogenous leukemia hematology 2017 standard therapy Turkey 22
685 bone marrow chronic granulomatous disease hematology 2017 standard therapy Poland 2
{{$index+1}} {{item.source}} {{item.indication}} {{item.area}} {{item.year}} {{item.therapy}} {{item.country}} {{item.age | number}}

Last update: Janury 2017